These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11920588)

  • 1. Transcriptional inactivation of TP73 expression in oligodendroglial tumors.
    Dong S; Pang JC; Hu J; Zhou LF; Ng HK
    Int J Cancer; 2002 Mar; 98(3):370-5. PubMed ID: 11920588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
    Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
    Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
    Anselmo NP; Rey JA; Almeida LO; Custódio AC; Almeida JR; Clara CA; Santos MJ; Casartelli C
    Genet Mol Res; 2009 Oct; 8(4):1257-63. PubMed ID: 19876867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.
    Li KK; Pang JC; Chung NY; Ng YL; Chan NH; Zhou L; Poon WS; Ng HK
    Int J Cancer; 2007 Feb; 120(4):947-50. PubMed ID: 17187361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
    Riemenschneider MJ; Reifenberger J; Reifenberger G
    Int J Cancer; 2008 Jun; 122(11):2503-10. PubMed ID: 18302158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
    Möllemann M; Wolter M; Felsberg J; Collins VP; Reifenberger G
    Int J Cancer; 2005 Jan; 113(3):379-85. PubMed ID: 15455350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.
    Dong SM; Pang JC; Poon WS; Hu J; To KF; Chang AR; Ng HK
    J Neuropathol Exp Neurol; 2001 Aug; 60(8):808-16. PubMed ID: 11487055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
    Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
    BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
    Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
    Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
    Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
    Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors.
    Kuo LT; Lu HY; Lee CC; Tsai JC; Lai HS; Tseng HM; Kuo MF; Tu YK
    Cancer Med; 2016 Aug; 5(8):1830-9. PubMed ID: 27367901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status.
    Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.
    Li Q; Athan ES; Wei M; Yuan E; Rice SL; Vonsattel JP; Mayeux RP; Tycko B
    BMC Med Genet; 2004 Jun; 5():14. PubMed ID: 15175114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3.
    Tsujimoto T; Mochizuchi S; Iwadate Y; Namba H; Nagai M; Kawamoto T; Sunahara M; Yamaura A; Nakagawara A; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(4):2495-7. PubMed ID: 10953317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
    Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
    Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.